Read testimonials from peers who are presenting their research at this year's Acute Cardiovascular Care congress in Lisbon!
ACCA Research Prize: scientists and clinicians are invited to submit their un-published research in the area of acute cardiovascular care with a focus on quality of care research, clinical outcomes research and translational research applied to the development of novel therapeutic, diagnostic and logistical strategies to improve patient care and long-term outcomes.
The ACCA Research Prize Winner will take place on Saturday 15 October from 14:00 to 15:30, room Coimbra. All finalists will benefit from a free registration to Acute Cardiovascular Care 2016 and the winner will receive a €3000 Prize. The Young Investigator Award (YIA) competition is designed for presenters who are 35 or under.
YIA Finalists will present their research and a panel of experts will judge and determine the winners on Sunday 16 October from 11:00 to 12:30, room Evora. All YIA finalists will benefit from a free registration to Acute Cardiovascular Care 2016 and will have the opportunity to submit a paper for FAST TRACK review & immediate publication in the EHJ-ACVC.
Can Tepeköylü (Innsbruck, Austria)
Can Tepeköylü studied Medicine at Medical University of Vienna. He was a visiting research assistant with Prof. Ching-Jen Wang at Chang Gung University College of Medicine in Kaohsiung, Taiwan. Can Tepeköylü obtained his PhD from the Molecular Cell Biology program at Innsbruck Medical University. He is a resident in Cardiac Surgery at the University Clinic of Cardiac Surgery, Innsbruck. His research avtivities are part of CARE, Cardiac Regeneration Research Group at Innsbruck Medical University (carelab.at) and focus on tissue regeneration via shock waves and molecular pathomechanisms of heart valve disease.
"Shock waves regenerate ischemic myocardium via exosome release"
Shock wave therapy (SWT) is developing a promising approach for the regeneration of ischemic myocardium. We show for the first time how the mechanical stimulus of SWT is translated into a biological response via the release of angiogenic exosomes.
Maximilian Mauler (Freiburg, Germany)
I studied biology at the University of Freiburg in Germany where i also worked on my diploma thesis “A new synthetic mammalian signaling system for cell-cell communication” in the group of Prof. Dr. Wilfried Weber at the Center for Biological Signaling Studies, BIOSS, Freiburg. I graduated in 2010 and joined the group of Dr. Daniel Duerschmied at the University Heart Center Freiburg in 2011 as research associate where I study the contribution of platelets to inflammatory processes in general and the effect of platelet serotonin on other cells of the immune system.
"Pharmacologic depletion of platelet serotonin improves the outcome after myocardial reperfusion injury"
Platelet serotonin regulates neutrophil migration during the inflammatory response of reperfusion injury and depletion of serotonin greatly improves the outcome after myocardial infarction.
Philipp Emanuel Bartko (Vienna, Autria)
My core scientific focus is on extracorporeal circulatory support in critically ill patients under the supervision of Prof. Georg Goliasch at the medical University of Vienna. During my Marie-Curie fellowship at MGH, Harvard University, mentored by Professor Robert Levine, I gained particular strength in cardiovascular-imaging particularly cardiac-function. My PhD thesis explored new imaging techniques to improve echocardiographic risk prediction within a multinational framework (TOPAS-Study). As the national representative of the European association of cardiovascular imaging I have the opportunity to add my experience at the interface of cardiovascular imaging and critical care cardiology to set the foundation for strategies towards improved care in critically ill patients.
"Impact of right-ventricular performance in patients undergoing extracorporeal membrane oxygenation following cardiac surgery"
Assessment of right-ventricular function provides a comprehensive set of metrics for risk stratification and underlines the hemodynamic significance of the right ventricle in patients in need of mechanical circulatory support.
Shah Anoop (Edinburgh, United Kingdom)
Anoop was born in Nairobi and grew up in Kenya moving to the United Kingdom in 1998. He studied Medicine at the University of Edinburgh, graduating in 2006. His postgraduate training in internal medicine was completed in the South East of Scotland after which he joined the Centre of Cardiovascular Science at the University of Edinburgh in 2011. During this time he completed his Masters in Public Health and PhD in cardiovascular epidemiology. His research interests include understanding the epidemiological trends in the incidence and diagnosis of common cardiovascular pathologies. He is involved in multi-centre cluster randomized clinical trials using routine data sources to evaluate the role of cardiac biomarkers in evaluating patients with suspected acute coronary syndrome.
"High-sensitivity cardiac troponin testing and the diagnosis of myocardial infarction"
Claus Kjaer Perdersen (Odder, Denmark)
I am employed at the Research Unit, Department of Cardiology, Aarhus University Hospital, Denmark.
I am a member of a research group, which for more than a decade has been involved in research within prehospital diagnostics and management of cardiac patients, mainly patients suspected of ACS.
Currently, I am performing a randomized controlled trial, evaluating the combination of prehospital copeptin and in-hospital hs-cTnT for early rule-out of AMI, which is planned to include 4800 patients during the next few years.
"Prehospital high-sensitivity troponin T and copeptin predicts outcome and may allow prehospital rule-out of acute myocardial infarction"
Prehospital hs-cTnT and copeptin may allow rule-out of 45% of patients with suspected AMI. Elevated hs-cTnT and copeptin may be used to prehospital identification of high-risk patients.
Fabienne Witassek (Zurich, Swisterland)
Fabienne Witassek, born 1981 in Switzerland, works as a research assistant in the Swiss myocardial infarction registry AMIS Plus, at the Epidemiology, Biostatistics and Prevention Institute of the University of Zurich. After studying nutrition and dietetics at the College of Higher Education Zurich, she earned her master’s degree in human biology at the University of Zurich. For her master’s thesis she performed a study on the obesity paradox in patients with myocardial infarction. She has further focussed her research on heart diseases, the risk factors and their management, and has been co-authoring and contributing to several publications in these areas.
"Immediate treatment and outcome of cancer patients with acute myocardial infarction"
Myocardial infarction (MI) patients with a history of cancer were less likely to receive guideline-recommended treatment and had worse cardiac in-hospital outcomes than MI patients without cancer.
Joana Moura Ferreira (Santa Maria Da Feira, Portugal)
Joana Moura Ferreira graduated from Oporto Medical School in 2008 and is currently a Cardiology Fellow in Centro Hospitalar e Universitário de Coimbra. She is also a student of the PhD Program of Cardiovascular Sciences in Oporto Medical School since 2013.
"Cardiopulmonary exercise test predicts invasively measured pulmonary vascular resistance in end stage heart failure patients"
Cardiopulmonary exercise test parameters VE/VCO2 slope and peak O2 pulse predicts invasively measured pulmonary vascular resistance in end stage heart failure patients.
João Bicho Augusto (Pinhal Novo, Portugal)
João Bicho Augusto obtained his Master’s Degree in Medicine in the Faculty of Medicine of the University of Lisbon, Portugal (2012). His master’s thesis focused on the diagnosis of coronary artery anomalies. Currently he is a resident in Cardiology at Fernando Fonseca Hospital, Portugal (2013). His main professional fields of interest and practice are atrial fibrillation, echocardiography and cardiovascular magnetic resonance. Author of several lectures in scientific congresses, publications in national and international journals and one book chapter. Participation in international trials in the field of heart failure since 2015. Award winner of one Portuguese prize in the General Cardiology field.
“Mild troponin elevations in patients admitted to the emergency department with atrial fibrillation: 30-day prognostic significance after discharge”
A high proportion of patients with atrial fibrillation (AF) undergo troponin testing in the emergency department without clinical suspicion of acute coronary syndrome. We found that mild elevations of troponin levels are not associated with increased all-cause mortality, myocardial infarction or stroke 30 days after discharge. Thus, troponin levels should not be routinely obtained in all patients with AF.
Matilde Winther-Jensen (Copenhagen, Denmark)
2013: MSc in Biology
2013-2015: Research coordinator in Centre for Resuscitation Science in the Oresund Region, a Danish-Swedish multi-centre collaboration, lead by Rigshospitalet, administrating EU grant, affiliated with the research carried out in the centre.
2015: Research assistant, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital
2015: PhD fellow, Department of Cardiology, Rigshospitalet, with a focus on disparity and development in post-resuscitation care in Denmark using the Danish Cardiac Arrest Registry
Currently co-author of 10 peer-reviewed papers (4 as first author) within the field of out-of-hospital cardiac arrest and post-resuscitation care.
"Nationwide study of factors associated with implantation of implantable cardioverter defibrillator after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark 2001-2012"
In a nationwide registry based study ICD implantation in AMI-OHCA patients 2001-2012, we assessed which demographic and clinical factors influenced ICD implantation and whether implantation rates rose during the 10 year period.
Silvia Aguiar Rosa (Lisbon, Portugal)
Resident in Cardiology, 4th year of residency: Cardiology Department, Santa Marta Hospital, Lisbon, Portugal.Doctoral Program in Medicine – Clinical research, 2nd year; Nova Medical School, Lisbon, Portugal.
Examination of Acute Cardiac Care: Acute Cardiovascular Care Association, European Society of Cardiology, Geneve (Switzerland), 2014.Cardiovascular Magnetic Resonance Level 1, European Association of Cardiovascular Imaging, Florence, Italy 2016.
"Complete atrioventricular block in acute coronary syndrome. Prevalence, characterization and implication in outcome"
Acute coronary syndrome patients with complete AV block had worst outcome, including higher incidence of cardiogenic shock, ventricular arrhythmias and death.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved